Nxstage Medical (NXTM) Tops Q3 EPS by 4c

November 3, 2016 8:07 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Nxstage Medical (NASDAQ: NXTM) reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $92 million versus the consensus estimate of $89.82 million.

GUIDANCE:

Nxstage Medical sees FY2016 revenue of $360-365 million.

For earnings history and earnings-related data on Nxstage Medical (NXTM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment